Stefanos Theoharis, new CEO of OneChain Immunotherapeutics 01/02/2024 Corporate OneChain Immunotherapeutics (OCI), a clinical-stage biotechnology company focused on the development of CAR T therapies... Partners - Parc Científic de Barcelona
#AseBioGallery | This is how the 'AseBio Journalism Awards' went 26/02/2024 Communication Talento Corporate The awards recognized the work of Belén Diego, collaborator for Diariofarma and correspondent for APM Health Europe in... AseBio
#NewAseBioMember | “AseBio providing an unparalleled platform to collaborate with other co... 23/02/2024 Corporate Meet Cobiomic Biosciences, our new member. We talked to its Carlos Pérez Sánchez, fundador y director. AseBio - COBIOMIC BIOSCIENCES S.L.
Laboratorios Best Medical intensifies the development of powdered cosmetic products with n... 21/02/2024 Corporate Partners
Bioga leads IberoBio, a European project to create and propell the Cross-border Biotechnol... 21/02/2024 Corporate The Cluster Tecnolóxico Empresarial das Ciencias da Vida, who will be the captain of the initiative, presented said... Partners - BIOGA
Enzymlogic Marks 10 Years Transforming Drug Discovery Through Kinetic Profiling 16/02/2024 Corporate With the mission to revolutionize the way drugs are discovered, the company has pioneered two cutting-edge technological... Partners - Enzymlogic
#NewMemberAseBio | “AseBio is the support on which start-ups like Cocoon rely to navigate ... 15/02/2024 Corporate Meet Cocoon Bioscience, our new member. We talked to its Romy Dalton, COO & CSO. AseBio - COCOON BIOSCIENCE S.L.
#NewAseBioMember | “AseBio and ICON together, is a collaborative network for the biotechno... 09/02/2024 Corporate Meet ICON, our new member. We talked to its Pedro Vinals, Vice President, General Partner. AseBio
#NewAseBioMember | “AseBio seeks to generate a high-added-value, and sustainable, producti... 07/02/2024 Corporate Meet Savana, our new member. We talked to its Antonio Urda, chief government affairs officer. AseBio - Savana
GENESIS Tech Transfer Boost incorporates a new investment partner, PINONO S.L. 06/02/2024 Corporate GENESIS Tech Transfer Boost is an investment vehicle created in 2022 that invests in the field of Biomedicine. Partners - GENESIS Biomed
